Cargando…
miR-132 serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell viability
BACKGROUND: Gestational diabetes mellitus (GDM) leads to poor pregnancy outcomes. Strategies that improve trophoblast cell function are important methods for GDM treatment. This study aimed to investigate the expression and diagnostic potential of microRNA-132 (miR-132) in GDM patients, and further...
Autores principales: | Zhou, Xuegui, Xiang, Cuiping, Zheng, Xiaoxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814988/ https://www.ncbi.nlm.nih.gov/pubmed/31653266 http://dx.doi.org/10.1186/s13000-019-0899-9 |
Ejemplares similares
-
MicroRNA-1323 serves as a biomarker in gestational diabetes mellitus and aggravates high glucose-induced inhibition of trophoblast cell viability by suppressing TP53INP1
por: Liu, Lijun, et al.
Publicado: (2021) -
Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma
por: Weber, Daniel G., et al.
Publicado: (2017) -
miR-377 inhibition enhances the survival of trophoblast cells via upregulation of FNDC5 in gestational diabetes mellitus
por: Hua, Zhaozhao, et al.
Publicado: (2021) -
Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease
por: Zhang, Ming, et al.
Publicado: (2021) -
miR-132 is upregulated in polycystic ovarian syndrome and inhibits granulosa cells viability by targeting Foxa1
por: Cui, Xiangrong, et al.
Publicado: (2020)